Skip to main content
. 2018 May 4;9(34):23608–23619. doi: 10.18632/oncotarget.25286

Table 2C. Late toxicities (n = 194).

Late toxicity Yes (%) No (%) Unknown (%)
Pulmonary (0) (100) (0)
Cardiac (0) (100) (0)
Cutaneous 60 (31) 130 (67) 4 (2)
Grade 1 (%) Grade 2 (%) Grade 3 (%)
Hyperpigmentation 18 (9) 1 (1) 0
Breast oedema 14 (7) 1 (1) 0
Fibrosis 24 (12) 3 (2) 0
Telangiectasia 4 (6) 2 (1) 0
Breast pain 11 (6) 1 (1) 0